Literature DB >> 24633212

Awakening properties of isoflurane, sevoflurane, and desflurane in pediatric patients after craniotomy for supratentorial tumours.

Ayman A Ghoneim1, Magda S Azer, Hossam Z Ghobrial, Mohammed A El Beltagy.   

Abstract

BACKGROUND: The aim of this prospective, comparative, randomized study was to compare the inhalational anesthetics isoflurane, sevoflurane, and desflurane in pediatric patients undergoing craniotomy for excision of supratentorial tumors. We assessed early postoperative recovery outcome, intraoperative hemodynamics, and degree of brain swelling, as well as postoperative vomiting and shivering.
METHODS: Sixty patients scheduled for supratentorial brain tumor excision, were randomly allocated into 1 of 3 groups (20 patients each); isoflurane, sevoflurane, and desflurane group. After IV induction of anesthesia, maintenance was achieved using the inhalational anesthetic according to the allocated group. Tracheal extubation time was the primary endpoint. The secondary endpoints included: emergence time and the interval time needed to reach Aldrete score ≥9, intraoperative degree of brain swelling, intraoperative heart rate and mean arterial blood pressure, as well as postoperative vomiting and shivering.
RESULTS: The mean emergence time, extubation time, and the interval required to reach Aldrete score 9 were significantly shorter in the desflurane and sevoflurane groups than the isoflurane group. No statistically significant changes in the 3 groups regarding intraoperative brain swelling, hemodynamics, and postoperative shivering or vomiting were noted.
CONCLUSIONS: Desflurane and sevoflurane can be used to facilitate early emergence from anesthesia in neurosurgical pediatric patients. Emergence times are shorter with desflurane or sevoflurane than with isoflurane. The patients who received desflurane or sevoflurane have similar intraoperative and postoperative incidence of adverse effects compared with those who received isoflurane. Thus, desflurane and sevoflurane can be considered as suitable for emergence in pediatric neurosurgical anesthesia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24633212     DOI: 10.1097/ANA.0000000000000058

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  6 in total

Review 1.  [Neuroanesthesia].

Authors:  K Engelhard
Journal:  Anaesthesist       Date:  2016-02       Impact factor: 1.041

2.  Awakening arterial blood and end-tidal concentrations of isoflurane in female surgical patients.

Authors:  Tso-Chou Lin; Chih-Cherng Lu; Che-Hao Hsu; Joseph V Pergolizz; Cheng-Chang Chang; Meei-Shyuan Lee; Shung-Tai Ho
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  Perioperative Management of Subarachnoid Hemorrhage in a Patient with Alagille Syndrome and Unrepaired Tetralogy of Fallot: Case Report.

Authors:  Juan Fiorda-Diaz; Muhammad Shabsigh; Galina Dimitrova; Suren Soghomonyan; Gurneet Sandhu
Journal:  Front Surg       Date:  2017-12-04

Review 4.  A clinical review of inhalation anesthesia with sevoflurane: from early research to emerging topics.

Authors:  Jorge D Brioni; Shane Varughese; Raza Ahmed; Berthold Bein
Journal:  J Anesth       Date:  2017-06-05       Impact factor: 2.078

5.  Sevoflurane Inhibited Osteosarcoma Cell Proliferation And Invasion Via Targeting miR-203/WNT2B/Wnt/β-Catenin Axis.

Authors:  Meixian Chen; Lisheng Zhou; Zhaoxia Liao; Xijiu Ye; Xujun Xuan; Beibei Gu; Fuding Lu
Journal:  Cancer Manag Res       Date:  2019-11-11       Impact factor: 3.989

6.  Efficacy and safety of sevoflurane vs propofol in combination with remifentanil for anesthesia maintenance during craniotomy: A meta-analysis.

Authors:  Zheng Zhou; Miaofa Ying; Rui Zhao
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.